Cargando…
Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases
Millions of people are suffering from Alzheimer’s disease globally, but there is still no effective treatment for this neurodegenerative disease. Thus, novel therapeutic approaches for Alzheimer’s disease are needed, which requires further evaluation of the regulatory mechanisms of protein aggregate...
Autores principales: | Xue, Wenlong, Zhang, Jie, Li, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360109/ https://www.ncbi.nlm.nih.gov/pubmed/37282455 http://dx.doi.org/10.4103/1673-5374.371346 |
Ejemplares similares
-
Enhanced lysosome biogenesis ameliorates neurodegenerative diseases
por: Xue, Wenlong, et al.
Publicado: (2022) -
Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022) -
TFEB acetylation promotes lysosome biogenesis and ameliorates Alzheimer’s disease–relevant phenotypes in mice
por: Li, Tianyou, et al.
Publicado: (2022) -
Lysosome biogenesis: Regulation and functions
por: Yang, Chonglin, et al.
Publicado: (2021) -
LYECs: lysosome-enhancing compounds as potential therapeutic approaches for Alzheimer disease
por: Yin, Limin, et al.
Publicado: (2022)